Borosil Scientific LimitedQ1 FY27 Results & Financial Update
Borosil Scientific Limited: Q1 FY27 consolidated results and company financials – revenue ₹106.75 Cr, PAT ₹4.36 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Borosil Scientific price & chart
Market price₹102.01
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Borosil Scientific Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
For the quarter ended June 30, 2026, Borosil Scientific Limited reported consolidated revenue from operations of INR 106.75 crore and total income of INR 109.42 crore.
Profit before share of profit in associate, exceptional items and tax stood at INR 5.98 crore, which matches the consolidated Profit Before Tax (PBT) of INR 5.98 crore for the period.
Consolidated net profit (Profit for the Period) reached INR 4.36 crore after factoring in total tax expenses of INR 1.63 crore.
Basic and diluted earnings per share (EPS) for the quarter were recorded at INR 0.49 each, not annualized.
The consolidated results incorporate the financial performance of subsidiary Goel Scientific Glass Works Limited, whose interim financial results reflect total revenue of INR 7.63 crore and a net loss after tax of INR 2.36 crore for the quarter.
On a standalone basis, the company posted revenue from operations of INR 99.90 crore and a net profit of INR 6.84 crore, supported by a standalone PBT of INR 9.31 crore.
Board proceedings during the quarter also included approvals for amendments to the company's ESOP schemes (SP-ESOP 2023 and BSL ESOS) to facilitate share arrangements via primary issuance or secondary acquisition through a trust route and to adjust grant discount limits.
Profit before tax stood at INR 5.98 crore, while profit for the period reached INR 4.35 crore, yielding basic and diluted earnings per share of INR 0.49.
01 · Business model
What does Borosil Scientific do?
Borosil Scientific Limited operates as a manufacturer and supplier of scientific laboratory glass, equipment, process systems, pharmaceutical primary packaging, and domestic glassware items.
The company's core product portfolio serves analytical laboratories, production floors, research and development facilities, and pharmaceutical packaging requirements.
Operations span multiple operating segments, primarily categorized under Scientific - Laboratory Glass & equipment and Process System, Glassware, and other specialized items such as filter papers.
The business model integrates in-house manufacturing units—such as its facility located at Village Ambad in Nashik, Maharashtra—with distribution networks servicing institutional and retail clienteles.
02 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹106.75 Cr |
| Total income | ₹109.42 Cr |
| Profit before tax | ₹5.98 Cr |
| Profit after tax | ₹4.36 Cr |
| EPS | ₹0.49 |
03 · Why it moved
Why the quarter looked the way it did
What drove revenue
The Scientific - Laboratory Glass & equipment and Process System segment generated consolidated revenue of INR 66.68 crore during the quarter.
The Glassware segment, encompassing pharmaceutical primary packaging and domestic items, contributed consolidated revenue of INR 38.36 crore.
Other product categories, including filter paper and related items, added INR 1.71 crore to consolidated revenue.
The Scientific - Laboratory Glass & equipment and Process System segment remained the primary revenue driver, generating INR 66.68 crore out of total consolidated revenue of INR 106.75 crore.
Consolidated revenue was supported by subsidiary Goel Scientific Glass Works Limited, which contributed INR 7.63 crore in quarterly total revenue.
What drove margins
Consolidated cost of materials consumed was INR 41.01 crore, alongside purchases of stock-in-trade of INR 0.45 crore and a positive inventory change of INR 8.14 crore.
Consolidated employee benefits expense stood at INR 21.98 crore for the quarter.
Depreciation and amortization expense was recorded at INR 4.89 crore, while finance costs amounted to INR 0.25 crore.
Cost of materials consumed represented INR 41.01 crore of consolidated expenses, while employee benefits expense accounted for INR 21.98 crore.
Other expenses stood at INR 43.00 crore and depreciation and amortization expense was INR 4.89 crore for the quarter.
Segment profitability varied between divisions, with the Scientific segment earning INR 9.36 crore before tax and unallocated items, while the Glassware segment generated INR 0.19 crore.
04 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The Scientific - Laboratory Glass & equipment and Process System segment registered a profit before tax and non-controlling interests of INR 9.36 crore on a consolidated basis.
The Glassware segment reported a consolidated profit before tax and non-controlling interests of INR 0.19 crore.
Generated INR 66.68 crore in segment revenue and INR 9.36 crore in segment profit before tax and non-controlling interests, with segment assets of INR 198.11 crore.
Recorded INR 38.36 crore in revenue and INR 0.19 crore in segment profit before tax, with segment assets standing at INR 127.65 crore.
Comprising items such as filter paper, this segment generated INR 1.71 crore in revenue and INR 0.43 crore in segment profit.
05 · Strategy & new businesses
How the company is trying to change its growth mix
The Board approved amendments to the SP-ESOP 2023 and BSL ESOS schemes to enable share provisioning for option holders through secondary acquisitions via a trust route in addition to direct primary issuances.
The Board of Directors approved amendments to the BSL ESOP and SP-ESOP 2023 schemes to facilitate share allotment via primary issuance or secondary acquisition through a trust route and to increase the maximum discount percentage for new options from 10% to 20%.
06 · Reported developments
What changed operationally
The Glassware segment returned to a positive segment result of INR 0.19 crore before tax, overcoming previous quarter losses.
07 · Pressure points & risks
What is not going smoothly
Subsidiary Goel Scientific Glass Works Limited reported a net loss after tax of INR 2.36 crore for the quarter ended June 30, 2026.
08 · Beyond the numbers
What changed beyond the numbers
Reported update
ESOP Discount Limit Amendment
The company proposed increasing the maximum discount percentage for grant of new options under BSL ESOS from 10% to 20% of the closing market price.
Reported update
ESOP Scheme Modification
The Board proposed amendments to employee stock option plans to allow secondary market acquisitions through a trust route in addition to direct primary issuance.
09 · Key Q&A
The quarter, answered directly
What does Borosil Scientific do?
Borosil Scientific Limited operates as a manufacturer and supplier of scientific laboratory glass, equipment, process systems, pharmaceutical primary packaging, and domestic glassware items.
What is the clearest takeaway from Q1 FY27?
For the quarter ended June 30, 2026, Borosil Scientific Limited reported consolidated revenue from operations of INR 106.75 crore and total income of INR 109.42 crore.
What drove revenue or demand?
The Scientific - Laboratory Glass & equipment and Process System segment generated consolidated revenue of INR 66.68 crore during the quarter.
What mattered most for margins or profitability?
Consolidated cost of materials consumed was INR 41.01 crore, alongside purchases of stock-in-trade of INR 0.45 crore and a positive inventory change of INR 8.14 crore.
What changed operationally beyond the headline numbers?
The Board approved amendments to the SP-ESOP 2023 and BSL ESOS schemes to enable share provisioning for option holders through secondary acquisitions via a trust route in addition to direct primary issuances.
What are the main pressure points disclosed for the quarter?
Subsidiary Goel Scientific Glass Works Limited reported a net loss after tax of INR 2.36 crore for the quarter ended June 30, 2026.
10 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
11 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Subsidiary Turnaround: Monitor the operational performance and loss-reduction progress at subsidiary Goel Scientific Glass Works Limited.
- 02
Segment Profitability: Track margin stabilization across the Scientific and Glassware operating divisions.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.